Pediatrix Medical Group, Inc. (MD) Earnings History
Annual and quarterly earnings data from 1994 to 2025
Loading earnings history...
MD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 24.7% | 12.1% | 8.6% |
| 2024 | 22.6% | -3.4% | -4.9% |
| 2023 | 21.1% | 0.4% | -3.0% |
| 2022 | 23.7% | 8.8% | 3.4% |
| 2021 | 26.9% | 10.6% | 6.9% |
Download Data
Export MD earnings history in CSV or JSON format
Free sign-in required to download data
Pediatrix Medical Group, Inc. (MD) Earnings Overview
As of May 8, 2026, Pediatrix Medical Group, Inc. (MD) reported trailing twelve-month net income of $174M, reflecting +263.0% year-over-year growth. The company earned $2.10 per diluted share over the past four quarters, with a net profit margin of 8.6%.
Looking at the long-term picture, MD's historical earnings data spans multiple years. The company achieved its highest annual net income of $336M in fiscal 2015.
Pediatrix Medical Group, Inc. maintains positive profitability with a gross margin of 24.7%, operating margin of 12.1%, and net margin of 8.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including THC ($1.70B net income, 6.6% margin), NKTR (-$164M net income, -297.1% margin), AMSF ($46M net income, 14.9% margin), MD has outperformed on profitability metrics. Compare MD vs THC →
MD Earnings vs Peers
Earnings metrics vs comparable public companies
MD Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $165M | +266.9% | $231M | $1.94 | 8.6% | 12.1% |
| 2024 | -$99M | -64.0% | -$69M | $-1.19 | -4.9% | -3.4% |
| 2023 | -$60M | -191.1% | $7M | $-0.73 | -3.0% | 0.4% |
| 2022 | $66M | -49.3% | $173M | $0.79 | 3.4% | 8.8% |
| 2021 | $131M | +116.4% | $203M | $1.52 | 6.9% | 10.6% |
| 2020 | -$796M | +46.8% | $98M | $-9.55 | -45.9% | 5.7% |
| 2019 | -$1.50B | -657.5% | $172M | $-17.94 | -84.2% | 9.7% |
| 2018 | $269M | -16.2% | $446M | $2.93 | 7.4% | 12.2% |
| 2017 | $320M | -1.4% | $480M | $3.42 | 9.3% | 13.9% |
| 2016 | $325M | -3.4% | $572M | $3.47 | 10.2% | 18.0% |
See MD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMD — Frequently Asked Questions
Quick answers to the most common questions about buying MD stock.
Is MD growing earnings?
MD EPS is $2.10, with earnings growth accelerating to +263.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $174M.
What are MD's profit margins?
Pediatrix Medical Group, Inc. net margin is +8.6%, with operating margin at +12.1%. Margins sit within typical range for the sector.
How consistent are MD's earnings?
MD earnings data spans 1994-2025. The accelerating earnings trend is +263.0% YoY. Historical data enables comparison across business cycles.